Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-06
2006-06-06
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S235000
Reexamination Certificate
active
07056920
ABSTRACT:
Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I):including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.
REFERENCES:
patent: 1085021 (1999-05-01), None
patent: 9808847 (1998-03-01), None
patent: 98008847 (1998-03-01), None
patent: 99038868 (1999-08-01), None
patent: 02072101 (2002-09-01), None
patent: 02072202 (2002-09-01), None
patent: 04035586 (2004-04-01), None
Chorvat et al. (J. Med. Chem. (2000), 42: 833-848).
(He et al. J. Med. Chem. (2000), 43:449-456).
Gilligan, Paul J. et al., Bioorganic & Medicinal Chemistry., 8 (2000), pp. 181-189.
Wermuth et al., The Practice of Medicinal Chemistry., 1996, pp. 203-237.
Appleman Jolene W.
Habte Kahsay
Pfizer Inc
Zelson Steve T.
LandOfFree
Pyrrolo[1,2-B]pyridazine compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo[1,2-B]pyridazine compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo[1,2-B]pyridazine compounds and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3680589